Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Sep;3(3):599-610.
doi: 10.1086/674327. Epub 2013 Dec 5.

Acute effects of sildenafil and dobutamine in the hypertrophic and failing right heart in vivo

Affiliations

Acute effects of sildenafil and dobutamine in the hypertrophic and failing right heart in vivo

Asger Andersen et al. Pulm Circ. 2013 Sep.

Abstract

Abstract The purpose of this study was to investigate whether acute intravenous administration of the phosphodiesterase type 5 (PDE-5) inhibitor sildenafil in a single clinically relevant dose improves the in vivo function of the hypertrophic and failing right ventricle (RV). Wistar rats ([Formula: see text]) were subjected to pulmonary trunk banding (PTB) causing RV hypertrophy and failure. Four weeks after surgery, they were randomized to receive an intravenous bolus dose of sildenafil (1 mg/kg; [Formula: see text]), vehicle ([Formula: see text]), or dobutamine (10 μg/kg; [Formula: see text]). Invasive RV pressures were recorded continuously, and transthoracic echocardiography was performed 1, 5, 15, 25, 35, 50, 70, and 90 minutes after injecting the bolus. Cardiac function was compared to baseline measurements to evaluate the in vivo effects of each specific treatment. The PTB procedure caused significant hypertrophy, cardiac fibrosis, and reduction in RV function evaluated by echocardiography (TAPSE) and invasive pressure measurements. Sildenafil did not improve the function of the hypertrophic failing right heart in vivo, measured by TAPSE, RV systolic pressure (RVsP), and dp/dtmax. Dobutamine improved RV function 1 minute after injection measured by TAPSE ([Formula: see text] vs. [Formula: see text] cm; [Formula: see text]), RVsP ([Formula: see text] vs. [Formula: see text] mmHg; [Formula: see text]), and dp/dtmax ([Formula: see text] vs. [Formula: see text] mmHg/s; [Formula: see text]). Acute administration of the PDE-5 inhibitor sildenafil in a single clinically relevant dose did not modulate the in vivo function of the hypertrophic failing right heart of the rat measured by echocardiography and invasive hemodynamics. In the same model, dobutamine acutely improved RV function.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Baseline characteristics. Results are plotted as mean ± standard error of the mean. One asterisk, formula image; three asterisks, formula image. Numbers plotted in the columns denote the number of animals used for analysis. RVW/LV+SW, right ventricle/left ventricle plus septum weight; TAPSE, tricuspid annular plane systolic excursion measured by transthoracic echocardiography; RVsP, right ventricular systolic pressure; dp/dtmax, maximum pressure development over time. PTB, pulmonary trunk banding; veh, vehicle; sil, sildenafil; dob, dobutamine.
Figure 2
Figure 2
Acute effects of sildenafil and dobutamine. Results are plotted as mean ± standard error of the mean. Three asterisks, formula image. Numbers plotted in the column denote the number of animals used for analysis. RVsP, right ventricular systolic pressure; TAPSE, tricuspid annular plane systolic excursion measured by transthoracic echocardiography; dp/dtmax, maximum pressure development over time; PTB, pulmonary trunk banding; ns, not significant.
Figure 3
Figure 3
Pulmonary trunk banding animals treated by dobutamine. Hemodynamic measurements at baseline and after injection of a single bolus of dobutamine 10 μg/kg. Results are plotted as mean ± standard error of the mean. Two asterisks, formula image; three asterisks, formula image compared to baseline measurement. TAPSE, tricuspid annular plane systolic excursion measured by transthoracic echocardiography; RVsP, right ventricular systolic pressure; RVPP, right ventricular pulse pressure product; dp/dtmax, maximum pressure development over time; dp/dtmin, minimum pressure development over time.
Figure 4
Figure 4
Pulmonary trunk branding animals treated by sildenafil. Hemodynamic measurements at baseline and after injection of a single bolus of sildenafil 1 mg/kg. Results are plotted as mean ± standard error of the mean. One asterisk, formula image; two asterisks, formula image; three asterisks, formula image compared to baseline measurement. TAPSE, tricuspid annular plane systolic excursion measured by transthoracic echocardiography; RVsP, right ventricular systolic pressure; RVPP, right ventricular pulse pressure product; dp/dtmax, maximum pressure development over time; dp/dtmin, minimum pressure development over time.
Figure 5
Figure 5
Pulmonary trunk branding animals treated by vehicle. Hemodynamic measurements at baseline and after injection of a single bolus of vehicle. Results are plotted as mean ± standard error of the mean. One asterisk, formula image compared to baseline measurement. TAPSE, tricuspid annular plane systolic excursion measured by transthoracic echocardiography; RVsP, right ventricular systolic pressure; RVPP, right ventricular pulse pressure product; dp/dtmax, maximum pressure development over time; dp/dtmin, minimum pressure development over time.
Figure 6
Figure 6
Sham-oriented animals treated by sildenafil. Hemodynamic measurements at baseline and after injection of a single bolus of sildenafil 1 mg/kg. Results are plotted as mean ± standard error of the mean. One asterisk, formula image; two asterisks, formula image compared to baseline measurement. TAPSE, tricuspid annular plane systolic excursion measured by transthoracic echocardiography; RVsP, right ventricular systolic pressure; RVPP, right ventricular pulse pressure product; dp/dtmax, maximum pressure development over time; dp/dtmin, minimum pressure development over time.

References

    1. Takimoto E, Champion HC, Li M, et al. Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy. Nat Med 2005;11(2):214–222. - PubMed
    1. Andersen A, Nielsen JM, Peters CD, Schou UK, Sloth E, Nielsen-Kudsk JE. Effects of phosphodiesterase-5 inhibition by sildenafil in the pressure overloaded right heart. Eur J Heart Fail 2008;10(12):1158–1165. - PubMed
    1. Schäfer S, Ellinghaus P, Janssen W, et al. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling. Cardiovasc Res 2009;82(1):30–39. - PubMed
    1. Borgdorff MAJ, Bartelds B, Dickinson MG, et al. Sildenafil enhances systolic adaptation, but does not prevent diastolic dysfunction, in the pressure-loaded right ventricle. Eur J Heart Fail 2012;14(9):1067–1074. - PubMed
    1. Shan X, Quaile MP, Monk JK, French B, Cappola TP, Margulies KB. Differential expression of PDE5 in failing and non-failing human myocardium. Circ Heart Fail 2012;5(1):79–86. - PMC - PubMed

LinkOut - more resources